Sort
48,018 grants matching “immunotherapy”
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells
$774,122Joji Fujisaki · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells
$774,122Joji Fujisaki · Beth Israel Deaconess Medical Center · R01 · FY2022 · HL
Identification and eliminationof HIV reservoirs in oral lymphoid tissues by engineered NK cells.
$773,997Jonathan Karn · Case Western Reserve University · R01 · FY2016 · DE
Induced tolerogenic dendritic cell therapy of allergic diseases
$773,988Ulrich H Von Andrian · Massachusetts General Hospital · U19 · FY2012 · AI
Pathogenesis of Hepatitis B Virus in Transgenic Mice
$773,963Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2007 · CA
Epigenome-wide association study of childhood asthma
$773,863Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2019 · AI
A Targeted Approach to Treat Immunotherapy-Induced Myocarditis with CXCR3 Blockade
$773,843Han Zhu · Stanford University · R01 · FY2025 · HL
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
$773,738Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2018 · AI
RCT of GnRH-a for ovarian protection during CYC therapy for rheumatic disease
$773,333William J Mc Cune · University Of Michigan At Ann Arbor · R01 · FY2010 · HD
Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failure
$773,285Arno W Tilles · Sentien Biotechnologies, Inc. · R44 · FY2012 · DK
Characteristics and protective efficacy of human antibodies against M. tuberculosis
$773,048Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Building better T cell receptors for targeted immunotherapy
$772,935Brian M Baker · University Of Notre Dame · R01 · FY2017 · AI
Developing broad-spectrum therapeutics against C. difficile toxins
$772,904Rongsheng Jin · University Of California-Irvine · R01 · FY2023 · AI
Epithelium-derived alarmins role in breast cancer immunoprevention
$772,892Shadmehr Demehri · Massachusetts General Hospital · U01 · FY2020 · CA
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
$772,657Adam Lacy-Hulbert · Massachusetts General Hospital · U01 · FY2010 · AI
Quadrupole Orbitrap Hybrid Mass Spectrometer for Proteomics
$772,652Lauren Elizabeth Ball · Medical University Of South Carolina · S10 · FY2021 · OD
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
$772,615John H Sampson · Annias Immunotherapeutics, Inc. · R42 · FY2017 · CA
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION
$772,609University Of Michigan At Ann Arbor · U01 · FY2002 · DK
Glycolysis and rodent models of Alzheimer's disease
$772,435Qiang Zhang · University Of Iowa · R01 · FY2024 · AG
VEL-03: IND-enabling development of a novel therapeutic approach for treatment of non-small cell lung cancer and other solid tumors
$772,293Richard Edward Showalter · Velorum Therapeutics Inc. · R44 · FY2025 · CA
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
$772,180Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Natural killer cell engineering to target the HIV reservoir
$772,072Jerome A. Zack · University Of California Los Angeles · R01 · FY2022 · AI
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
$772,064James R. Heath · Institute For Systems Biology · U54 · FY2024 · CA
NK/DC Cross-Talk and Antiviral Response
$772,006Luis J. Montaner · Wistar Institute · R01 · FY2011 · AI
Attenuating Inflammation to Restore GI Tract Integrity and Reduce Viral Reservoirs During cART
$771,835Jacob D Estes · Oregon Health & Science University · R01 · FY2021 · DK